Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.

N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17.

2.

Poster 207 Malpositioned Intrathecal Baclofen Pump Catheter Penetrating the Colon: A Case Report.

Benjamin SA, York HS.

PM R. 2016 Sep;8(9S):S228-S229. doi: 10.1016/j.pmrj.2016.07.244. Epub 2016 Sep 24. No abstract available.

PMID:
27672968
3.

Poster 136 Meta-Analysis of Non-Operative Modalities in the Treatment of Knee Pain in Osteoarthritis.

Benjamin SA, Leichliter AK, Jauregui JJ, Elmallah R.

PM R. 2016 Sep;8(9S):S206. doi: 10.1016/j.pmrj.2016.07.178. Epub 2016 Sep 24. No abstract available.

PMID:
27672903
4.

Do the Effects of Transcutaneous Electrical Nerve Stimulation on Knee Osteoarthritis Pain and Function Last?

Cherian JJ, Harrison PE, Benjamin SA, Bhave A, Harwin SF, Mont MA.

J Knee Surg. 2016 Aug;29(6):497-501. doi: 10.1055/s-0035-1566735. Epub 2015 Nov 5.

PMID:
26540652
5.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

6.

Darapladib for preventing ischemic events in stable coronary heart disease.

STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L.

N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30.

7.

Evaluation of a worksite wellness program designed to reduce cardiovascular risks.

Roblin DW, Robinson BE, Benjamin SA.

J Ambul Care Manage. 2013 Oct-Dec;36(4):272-9. doi: 10.1097/JAC.0b013e3182a3e728.

PMID:
24402067
8.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators.

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

9.

Nonadditive hepatic tumor promoting effects by a mixture of two structurally different polychlorinated biphenyls in female rat livers.

Dean CE Jr, Benjamin SA, Chubb LS, Tessari JD, Keefe TJ.

Toxicol Sci. 2002 Mar;66(1):54-61.

PMID:
11861972
10.

Pharmacokinetics, metabolism, and carcinogenicity of arsenic.

Pott WA, Benjamin SA, Yang RS.

Rev Environ Contam Toxicol. 2001;169:165-214. Review.

PMID:
11330077
11.

A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator.

Thomas RS, Conolly RB, Gustafson DL, Long ME, Benjamin SA, Yang RS.

Toxicol Appl Pharmacol. 2000 Jul 15;166(2):128-37.

PMID:
10896854
13.

Lack of promotional effects of groundwater contaminant mixtures on the induction of preneoplastic foci in rat liver.

Benjamin SA, Yang RS, Tessari JD, Chubb LW, Brown MD, Dean CE, Keefe TJ.

Toxicology. 1999 Oct 1;137(3):137-49.

PMID:
10522494
14.
15.

Antagonistic interactions of an arsenic-containing mixture in a multiple organ carcinogenicity bioassay.

Pott WA, Benjamin SA, Yang RS.

Cancer Lett. 1998 Nov 27;133(2):185-90.

PMID:
10072168
16.

Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling.

Yang RS, Thomas RS, Gustafson DL, Campain J, Benjamin SA, Verhaar HJ, Mumtaz MM.

Environ Health Perspect. 1998 Dec;106 Suppl 6:1385-93. Review.

17.

Evidence for hepatocarcinogenic activity of pentachlorobenzene with intralobular variation in foci incidence.

Thomas RS, Gustafson DL, Pott WA, Long ME, Benjamin SA, Yang RS.

Carcinogenesis. 1998 Oct;19(10):1855-62.

PMID:
9806169
18.

Mortality in beagles irradiated during prenatal and postnatal development. II. Contribution of benign and malignant neoplasia.

Benjamin SA, Lee AC, Angleton GM, Saunders WJ, Keefe TJ, Mallinckrodt CH.

Radiat Res. 1998 Sep;150(3):330-48.

PMID:
9728662
19.

Mortality in beagles irradiated during prenatal and postnatal development. I. Contribution of non-neoplastic diseases.

Benjamin SA, Lee AC, Angleton GM, Saunders WJ, Keefe TJ, Mallinckrodt CH.

Radiat Res. 1998 Sep;150(3):316-29.

PMID:
9728661
20.

Use of a medium-term liver focus bioassay to assess the hepatocarcinogenicity of 1,2,4,5-tetrachlorobenzene and 1,4-dichlorobenzene.

Gustafson DL, Coulson AL, Feng L, Pott WA, Thomas RS, Chubb LS, Saghir SA, Benjamin SA, Yang RS.

Cancer Lett. 1998 Jul 3;129(1):39-44.

PMID:
9714333

Supplemental Content

Loading ...
Support Center